Analyze Diet
Electrophoresis2022; 44(1-2); 125-134; doi: 10.1002/elps.202200175

Enantioselective CE-MS analysis of ketamine metabolites in urine.

Abstract: The chiral drug ketamine has long-lasting antidepressant effects with a fast onset and is also suitable to treat patients with therapy-resistant depression. The metabolite hydroxynorketamine (HNK) plays an important role in the antidepressant mechanism of action. Hydroxylation at the cyclohexanone ring occurs at positions 4, 5, and 6 and produces a total of 12 stereoisomers. Among those, the four 6HNK stereoisomers have the strongest antidepressant effects. Capillary electrophoresis with highly sulfated γ-cyclodextrin (CD) as a chiral selector in combination with mass spectrometry (MS) was used to develop a method for the enantioselective analysis of HNK stereoisomers with a special focus on the 6HNK stereoisomers. The partial filling approach was applied in order to avoid contamination of the MS with the chiral selector. Concentration of the chiral selector and the length of the separation zone were optimized. With 5% highly sulfated γ-CD in 20 mM ammonium formate with 10% formic acid and a 75% filling the four 6HNK stereoisomers could be separated with a resolution between 0.79 and 3.17. The method was applied to analyze fractionated equine urine collected after a ketamine infusion and to screen the fractions as well as unfractionated urine for the parent drug ketamine and other metabolites, including norketamine and dehydronorketamine.
Publication Date: 2022-12-09 PubMed ID: 36398998PubMed Central: PMC10108174DOI: 10.1002/elps.202200175Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The researchers of this paper developed a method to analyze the various forms of a ketamine metabolite, hydroxynorketamine (HNK), using capillary electrophoresis with highly sulfated γ-cyclodextrin as a chiral selector in combination with mass spectrometry (MS). They specifically focused on the 6HNK stereoisomers, which are believed to have the strongest antidepressant effects among ketamine’s 12 stereoisomers.

Hydroxynorketamine and its importance in the antidepressant effects of ketamine

  • Ketamine, a chiral drug, is known for its rapid and lasting antidepressant effects and is helpful in treating patients who are resistant to other forms of antidepressant therapy.
  • It is metabolized in the body to produce a compound known as hydroxynorketamine (HNK).
  • HNK plays a significant role in ketamine’s antidepressant effects, and it is formed through a hydroxylation process which produces a total of 12 stereoisomers (3D arrangements of molecules and atoms).
  • Of these 12 HNK stereoisomers, the ones that exhibited the strongest antidepressant effects were the four 6HNK stereoisomers. Hence, the focus on this study is on these four 6HNK stereoisomers.

Development of a method to analyze HNK stereoisomers via capillary electrophoresis and mass spectrometry

  • The researchers used a scientific technique called capillary electrophoresis assisted by a chiral selector (γ-cyclodextrin) to separate and analyze the various HNK stereoisomers. This was complemented by mass spectrometry to identify and quantify these stereoisomers.
  • Importantly, they applied a ‘partial filling approach’ to prevent contamination of the mass spectrometer detector with the γ-cyclodextrin chiral selector. This approach allows for the sample and selector to be introduced separately into the capillary and to remain separate during the procedure.
  • Various parameters were optimized during the process, including the concentration of the γ-cyclodextrin and the length of the separation zone or capillary.

Results and Applications

  • The developed method allowed for the separation of the four 6HNK stereoisomers with a resolution ranging from 0.79 to 3.17.
  • The researchers were able to apply the method to analyze fractionated equine urine collected after a ketamine infusion.
  • They also used it to identify not just the 6HNK stereoisomers, but other metabolites as well. This included the parent drug ketamine itself, as well as norketamine and dehydronorketamine.

Cite This Article

APA
Sandbaumhüter FA, Aerts JT, Theurillat R, Andrén PE, Thormann W, Jansson ET. (2022). Enantioselective CE-MS analysis of ketamine metabolites in urine. Electrophoresis, 44(1-2), 125-134. https://doi.org/10.1002/elps.202200175

Publication

ISSN: 1522-2683
NlmUniqueID: 8204476
Country: Germany
Language: English
Volume: 44
Issue: 1-2
Pages: 125-134

Researcher Affiliations

Sandbaumhüter, Friederike A
  • Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.
Aerts, Jordan T
  • Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.
Theurillat, Regula
  • Clinical Pharmacology Laboratory, Institute for Infectious Diseases, University of Bern, Bern, Switzerland.
Andrén, Per E
  • Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.
  • Science for Life Laboratory, Spatial Mass Spectrometry, Uppsala University, Uppsala, Sweden.
Thormann, Wolfgang
  • Clinical Pharmacology Laboratory, Institute for Infectious Diseases, University of Bern, Bern, Switzerland.
Jansson, Erik T
  • Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.

MeSH Terms

  • Animals
  • Horses
  • Ketamine
  • Stereoisomerism
  • Mass Spectrometry
  • Electrophoresis, Capillary / methods
  • Sulfates

Conflict of Interest Statement

The authors have declared no conflict of interest.

References

This article includes 44 references
  1. Kharasch ED, Labroo R. Metabolism of ketamine stereoisomers by human liver microsomes.. Anesthesiology 1992 Dec;77(6):1201-7.
  2. Zhang Y, Ye F, Zhang T, Lv S, Zhou L, Du D, Lin H, Guo F, Luo C, Zhu S. Structural basis of ketamine action on human NMDA receptors.. Nature 2021 Aug;596(7871):301-305.
    pubmed: 34321660doi: 10.1038/s41586-021-03769-9google scholar: lookup
  3. Mion G, Villevieille T. Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings).. CNS Neurosci Ther 2013 Jun;19(6):370-80.
    pmc: PMC6493357pubmed: 23575437doi: 10.1111/cns.12099google scholar: lookup
  4. Zanos P, Moaddel R, Morris PJ, Georgiou P, Fischell J, Elmer GI, Alkondon M, Yuan P, Pribut HJ, Singh NS, Dossou KS, Fang Y, Huang XP, Mayo CL, Wainer IW, Albuquerque EX, Thompson SM, Thomas CJ, Zarate CA Jr, Gould TD. NMDAR inhibition-independent antidepressant actions of ketamine metabolites.. Nature 2016 May 26;533(7604):481-6.
    pmc: PMC4922311pubmed: 27144355doi: 10.1038/nature17998google scholar: lookup
  5. Kohtala S. Ketamine-50 years in use: from anesthesia to rapid antidepressant effects and neurobiological mechanisms.. Pharmacol Rep 2021 Apr;73(2):323-345.
    pmc: PMC7994242pubmed: 33609274doi: 10.1007/s43440-021-00232-4google scholar: lookup
  6. Toki H, Ichikawa T, Mizuno-Yasuhira A, Yamaguchi JI. A rapid and sensitive chiral LC-MS/MS method for the determination of ketamine and norketamine in mouse plasma, brain and cerebrospinal fluid applicable to the stereoselective pharmacokinetic study of ketamine.. J Pharm Biomed Anal 2018 Jan 30;148:288-297.
    pubmed: 29126076doi: 10.1016/j.jpba.2017.09.033google scholar: lookup
  7. Riggs LM, Gould TD. Ketamine and the Future of Rapid-Acting Antidepressants.. Annu Rev Clin Psychol 2021 May 7;17:207-231.
  8. Highland JN, Morris PJ, Konrath KM, Riggs LM, Hagen NR, Zanos P, Powels CF, Moaddel R, Thomas CJ, Wang AQ, Gould TD. Hydroxynorketamine Pharmacokinetics and Antidepressant Behavioral Effects of (2,6)- and (5R)-Methyl-(2R,6R)-hydroxynorketamines.. ACS Chem Neurosci 2022 Feb 16;13(4):510-523.
  9. Highland JN, Zanos P, Riggs LM, Georgiou P, Clark SM, Morris PJ, Moaddel R, Thomas CJ, Zarate CA Jr, Pereira EFR, Gould TD. Hydroxynorketamines: Pharmacology and Potential Therapeutic Applications.. Pharmacol Rev 2021 Apr;73(2):763-791.
    pmc: PMC7938660pubmed: 33674359doi: 10.1124/pharmrev.120.000149google scholar: lookup
  10. Portmann S, Kwan HY, Theurillat R, Schmitz A, Mevissen M, Thormann W. Enantioselective capillary electrophoresis for identification and characterization of human cytochrome P450 enzymes which metabolize ketamine and norketamine in vitro.. J Chromatogr A 2010 Dec 17;1217(51):7942-8.
    pubmed: 20609441doi: 10.1016/j.chroma.2010.06.028google scholar: lookup
  11. Yanagihara Y, Kariya S, Ohtani M, Uchino K, Aoyama T, Yamamura Y, Iga T. Involvement of CYP2B6 in n-demethylation of ketamine in human liver microsomes.. Drug Metab Dispos 2001 Jun;29(6):887-90.
    pubmed: 11353758
  12. Zhao X, Venkata SL, Moaddel R, Luckenbaugh DA, Brutsche NE, Ibrahim L, Zarate CA Jr, Mager DE, Wainer IW. Simultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment-resistant bipolar depression.. Br J Clin Pharmacol 2012 Aug;74(2):304-14.
  13. Desta Z, Moaddel R, Ogburn ET, Xu C, Ramamoorthy A, Venkata SL, Sanghvi M, Goldberg ME, Torjman MC, Wainer IW. Stereoselective and regiospecific hydroxylation of ketamine and norketamine.. Xenobiotica 2012 Nov;42(11):1076-87.
  14. Schmitz A, Theurillat R, Lassahn PG, Mevissen M, Thormann W. CE provides evidence of the stereoselective hydroxylation of norketamine in equines.. Electrophoresis 2009 Aug;30(16):2912-21.
    pubmed: 19653235doi: 10.1002/elps.200900221google scholar: lookup
  15. Zarate CA Jr, Brutsche N, Laje G, Luckenbaugh DA, Venkata SL, Ramamoorthy A, Moaddel R, Wainer IW. Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression.. Biol Psychiatry 2012 Aug 15;72(4):331-8.
  16. Moaddel R, Sanghvi M, Dossou KS, Ramamoorthy A, Green C, Bupp J, Swezey R, O'Loughlin K, Wainer IW. The distribution and clearance of (2S,6S)-hydroxynorketamine, an active ketamine metabolite, in Wistar rats.. Pharmacol Res Perspect 2015 Aug;3(4):e00157.
    pmc: PMC4492732pubmed: 26171236doi: 10.1002/prp2.157google scholar: lookup
  17. Sandbaumhüter FA, Theurillat R, Thormann W. Separation of hydroxynorketamine stereoisomers using capillary electrophoresis with sulfated β-cyclodextrin and highly sulfated γ-cyclodextrin.. Electrophoresis 2017 Aug;38(15):1878-1885.
    pubmed: 28213944doi: 10.1002/elps.201700016google scholar: lookup
  18. Moaddel R, Venkata SL, Tanga MJ, Bupp JE, Green CE, Iyer L, Furimsky A, Goldberg ME, Torjman MC, Wainer IW. A parallel chiral-achiral liquid chromatographic method for the determination of the stereoisomers of ketamine and ketamine metabolites in the plasma and urine of patients with complex regional pain syndrome.. Talanta 2010 Oct 15;82(5):1892-904.
  19. Fassauer GM, Hofstetter R, Hasan M, Oswald S, Modeß C, Siegmund W, Link A. Ketamine metabolites with antidepressant effects: Fast, economical, and eco-friendly enantioselective separation based on supercritical-fluid chromatography (SFC) and single quadrupole MS detection.. J Pharm Biomed Anal 2017 Nov 30;146:410-419.
    pubmed: 28926735doi: 10.1016/j.jpba.2017.09.007google scholar: lookup
  20. Hasan M, Hofstetter R, Fassauer GM, Link A, Siegmund W, Oswald S. Quantitative chiral and achiral determination of ketamine and its metabolites by LC-MS/MS in human serum, urine and fecal samples.. J Pharm Biomed Anal 2017 May 30;139:87-97.
    pubmed: 28279931doi: 10.1016/j.jpba.2017.02.035google scholar: lookup
  21. Kurzweil L, Danyeli L, Şen ZD, Fejtova A, Walter M, Gensberger-Reigl S. Targeted mass spectrometry of ketamine and its metabolites cis-6-hydroxynorketamine and norketamine in human blood serum.. J Chromatogr B Analyt Technol Biomed Life Sci 2020 Sep 1;1152:122214.
    pubmed: 32531641doi: 10.1016/j.jchromb.2020.122214google scholar: lookup
  22. Sandbaumhüter FA, Thormann W. Enantioselective capillary electrophoresis provides insight into the phase II metabolism of ketamine and its metabolites in vivo and in vitro.. Electrophoresis 2018 Jun;39(12):1478-1481.
    pubmed: 29572863doi: 10.1002/elps.201800012google scholar: lookup
  23. Sandbaumhüter FA, Theurillat R, Thormann W. Effects of medetomidine and its active enantiomer dexmedetomidine on N-demethylation of ketamine in canines determined in vitro using enantioselective capillary electrophoresis.. Electrophoresis 2015 Nov;36(21-22):2703-2712.
    pubmed: 26104860doi: 10.1002/elps.201500147google scholar: lookup
  24. Theurillat R, Sandbaumhüter FA, Bettschart-Wolfensberger R, Thormann W. Microassay for ketamine and metabolites in plasma and serum based on enantioselective capillary electrophoresis with highly sulfated γ-cyclodextrin and electrokinetic analyte injection.. Electrophoresis 2016 May;37(9):1129-38.
    pubmed: 26626946doi: 10.1002/elps.201500468google scholar: lookup
  25. Schmitz A, Thormann W, Moessner L, Theurillat R, Helmja K, Mevissen M. Enantioselective CE analysis of hepatic ketamine metabolism in different species in vitro.. Electrophoresis 2010 May;31(9):1506-16.
    pubmed: 20358543doi: 10.1002/elps.200900703google scholar: lookup
  26. Moini M, Rollman CM. Compatibility of highly sulfated cyclodextrin with electrospray ionization at low nanoliter/minute flow rates and its application to capillary electrophoresis/electrospray ionization mass spectrometric analysis of cathinone derivatives and their optical isomers.. Rapid Commun Mass Spectrom 2015 Feb 15;29(3):304-10.
    pubmed: 26411628doi: 10.1002/rcm.7106google scholar: lookup
  27. Yan B, Huang ZA, Yahaya N, Chen DDY. Enantioselective analysis in complex matrices using capillary electrophoresis-mass spectrometry: A case study of the botanical drug Corydalis Rhizoma.. J Chromatogr B Analyt Technol Biomed Life Sci 2020 Sep 1;1152:122216.
    pubmed: 32531643doi: 10.1016/j.jchromb.2020.122216google scholar: lookup
  28. Valtcheva L, Mohannad J, Petterson G, Hjertén S. Chiral separation of β‐blockers by high‐performance capillary electrophoresis based on non‐immobilized cellulase as enantioselective protein. J Chromatogr 1993;638:263–7.
  29. Tanaka Y, Otsuka K, Terabe S. Separation of enantiomers by capillary electrophoresis-mass spectrometry employing a partial filling technique with a chiral crown ether.. J Chromatogr A 2000 Apr 14;875(1-2):323-30.
    pubmed: 10839152doi: 10.1016/s0021-9673(99)01334-5google scholar: lookup
  30. Rudaz S, Geiser L, Souverain S, Prat J, Veuthey JL. Rapid stereoselective separations of amphetamine derivatives with highly sulfated gamma-cyclodextrin.. Electrophoresis 2005 Oct;26(20):3910-20.
    pubmed: 16167308doi: 10.1002/elps.200500177google scholar: lookup
  31. Fanali S, Desiderio C, Schulte G, Heitmeier S, Strickmann D, Chankvetadze B. Chiral capillary electrophoresis‐electrospray mass spectrometry coupling using vancomycin as chiral selector. J Chromatogr A 1998;800:69–76.
  32. Lee S, Kim SJ, Bang E, Na YC. Chiral separation of intact amino acids by capillary electrophoresis-mass spectrometry employing a partial filling technique with a crown ether carboxylic acid.. J Chromatogr A 2019 Feb 8;1586:128-138.
    pubmed: 30558847doi: 10.1016/j.chroma.2018.12.001google scholar: lookup
  33. Xia S, Zhang L, Lu M, Qiu B, Chi Y, Chen G. Enantiomeric separation of chiral dipeptides by CE-ESI-MS employing a partial filling technique with chiral crown ether.. Electrophoresis 2009 Aug;30(16):2837-44.
    pubmed: 19655329doi: 10.1002/elps.200800799google scholar: lookup
  34. Sánchez-Hernández L, Domínguez-Vega E, Montealegre C, Castro-Puyana M, Marina ML, Crego AL. Potential of vancomycin for the enantiomeric resolution of FMOC-amino acids by capillary electrophoresis-ion-trap-mass spectrometry.. Electrophoresis 2014 May;35(9):1244-50.
    pubmed: 24338646doi: 10.1002/elps.201300489google scholar: lookup
  35. Morris PJ, Moaddel R, Zanos P, Moore CE, Gould TD, Zarate CA Jr, Thomas CJ. Synthesis and N-Methyl-d-aspartate (NMDA) Receptor Activity of Ketamine Metabolites.. Org Lett 2017 Sep 1;19(17):4572-4575.
    pmc: PMC5641405pubmed: 28829612doi: 10.1021/acs.orglett.7b02177google scholar: lookup
  36. Knobloch M, Portier CJ, Levionnois OL, Theurillat R, Thormann W, Spadavecchia C, Mevissen M. Antinociceptive effects, metabolism and disposition of ketamine in ponies under target-controlled drug infusion.. Toxicol Appl Pharmacol 2006 Nov 1;216(3):373-86.
    pmc: PMC2039908pubmed: 16919695doi: 10.1016/j.taap.2006.06.011google scholar: lookup
  37. Nemes P, Rubakhin SS, Aerts JT, Sweedler JV. Qualitative and quantitative metabolomic investigation of single neurons by capillary electrophoresis electrospray ionization mass spectrometry.. Nat Protoc 2013 Apr;8(4):783-99.
    pmc: PMC3655804pubmed: 23538882doi: 10.1038/nprot.2013.035google scholar: lookup
  38. Kwan HY, Thormann W. Enantioselective capillary electrophoresis for the assessment of CYP3A4-mediated ketamine demethylation and inhibition in vitro.. Electrophoresis 2011 Oct;32(19):2738-45.
    pubmed: 21983822doi: 10.1002/elps.201100095google scholar: lookup
  39. Schulte G, Heitmeier S, Chankvetadze B, Blaschke G. Chiral capillary electrophoresis‐electrospray mass spectrometry coupling with charged cyclodextrin derivatives as chiral selectors. J Chromatogr A 1998;800:77–82.
  40. Mikkonen S, Thormann W. Computer simulation of the enantioselective separation of weak bases in an online capillary electrophoresis based microanalysis configuration comprising sulfated cyclodextrin as selector.. Electrophoresis 2018 Jun;39(12):1482-1487.
    pubmed: 29645297doi: 10.1002/elps.201800113google scholar: lookup
  41. Dinis-Oliveira RJ. Metabolism and metabolomics of ketamine: a toxicological approach.. Forensic Sci Res 2017;2(1):2-10.
  42. Turfus SC, Parkin MC, Cowan DA, Halket JM, Smith NW, Braithwaite RA, Elliot SP, Steventon GB, Kicman AT. Use of human microsomes and deuterated substrates: an alternative approach for the identification of novel metabolites of ketamine by mass spectrometry.. Drug Metab Dispos 2009 Aug;37(8):1769-78.
    pmc: PMC2712439pubmed: 19448136doi: 10.1124/dmd.108.026328google scholar: lookup
  43. Lua AC, Lin HR. A rapid and sensitive ESI-MS screening procedure for ketamine and norketamine in urine samples.. J Anal Toxicol 2004 Nov-Dec;28(8):680-4.
    pubmed: 15538964doi: 10.1093/jat/28.8.680google scholar: lookup
  44. Savchuk SA, Rudenko BA, Brodskii ES, Formanovskii AA, Erofeev VV, Babanova EV. Application of gas chromatography with selective detection and gas chromatography‐mass spectrometry to identifying ketamine metabolites and to examining the conjugation of ketamine and its metabolites in human and rat organisms. J Anal Chem 1998;53:583–9.

Citations

This article has been cited 2 times.
  1. Aerts JT, Andrén PE, Jansson ET. Electrochemically Etched Tapered-Tip Stainless-Steel Electrospray-Ionization Emitters for Capillary Electrophoresis-Mass Spectrometry.. J Proteome Res 2023 Apr 7;22(4):1377-1380.
    doi: 10.1021/acs.jproteome.3c00076pubmed: 36866861google scholar: lookup
  2. Aerts JT, Andrén PE, Jansson ET. Zero-Degree Celsius Capillary Electrophoresis Electrospray Ionization for Hydrogen Exchange Mass Spectrometry.. Anal Chem 2023 Jan 17;95(2):1149-1158.
    doi: 10.1021/acs.analchem.2c03893pubmed: 36546842google scholar: lookup